These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 75267)

  • 41. The fatty acid levels of rat alpha-fetoprotein derived from fetuses, pregnancy and hepatoma sera.
    Nagai M; Becker JL; Deutsch HF
    Oncodev Biol Med; 1982; 3(5-6):343-50. PubMed ID: 6183647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Carcinofetal antigens (author's transl)].
    Hirai H
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):579-93. PubMed ID: 80809
    [No Abstract]   [Full Text] [Related]  

  • 43. The carcinogenic potential of aflatoxin or its metabolites in rats from dams fed aflatoxin pre- and postpartum.
    Grice HC; Moodie CA; Smith DC
    Cancer Res; 1973 Feb; 33(2):262-8. PubMed ID: 4347465
    [No Abstract]   [Full Text] [Related]  

  • 44. Liver differentiation and the estrogen-binding properties of alpha-fetoprotein.
    Uriel J; Aussel C; Bouillon D; Loisillier F; de Nechaud B
    Ann N Y Acad Sci; 1975 Aug; 259():119-30. PubMed ID: 54015
    [No Abstract]   [Full Text] [Related]  

  • 45. [Change in antioxidative activity of mice liver lipids during induction of hepatoma with orthoaminoazotoluol].
    Burlakova EB; Molochkina EM
    Biofizika; 1968; 13(3):443-8. PubMed ID: 4318229
    [No Abstract]   [Full Text] [Related]  

  • 46. Tumor induction in the progeny of mice receiving 4-nitroquinoline 1-oxide and N-methyl-N-nitrosourethan during pregnancy or lactation.
    Nomura T; Okamoto E; Tateishi N; Kimura S; Isa Y
    Cancer Res; 1974 Dec; 34(12):3373-8. PubMed ID: 4371957
    [No Abstract]   [Full Text] [Related]  

  • 47. Intracellular alpha-fetoprotein level in cultured ascites hepatoma cells of the rat determined as alpha-fetoprotein-negative.
    Isaka H; Koura M; Hattanmaru M; Yoshii H; Tsukada Y; Hirai H
    Gan; 1977 Oct; 68(5):709-10. PubMed ID: 73491
    [No Abstract]   [Full Text] [Related]  

  • 48. [Characteristics of alpha-fetoprotein synthesis in the early stages of hepatic carcinogenesis in mice with a various sensitivity to ortho-aminoazotoluene].
    Serova IA; Kaledin VI; Kostyrev OA; Gruntenko EV
    Dokl Akad Nauk SSSR; 1982; 263(5):1245-9. PubMed ID: 6178571
    [No Abstract]   [Full Text] [Related]  

  • 49. Liver carcinomas induced in rats by single administration of dimethylnitrosamine after partial hepatectomy.
    Craddock VM
    J Natl Cancer Inst; 1971 Oct; 47(4):899-907. PubMed ID: 4328955
    [No Abstract]   [Full Text] [Related]  

  • 50. Systemic promoting action of phorbol in liver and lung carcinogenesis in AKR mice.
    Armuth V; Berenblum I
    Cancer Res; 1972 Oct; 32(10):2259-62. PubMed ID: 4343013
    [No Abstract]   [Full Text] [Related]  

  • 51. A distinctive antigen present in liver carcinomas induced by 3'-methyl-p-dimethylaminoazobenzene.
    Carruthers C; Baumler A; Neilson A
    Oncology; 1977; 34(2):47-51. PubMed ID: 70767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
    Eleftheriou N; Heathcote J; Thomas HC; Sherlock S
    J Clin Pathol; 1977 Aug; 30(8):704-8. PubMed ID: 74380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatocarcinogenicity of polychlorinated biphenyls in mice.
    Nagasaki H; Tomii S; Mega T; Marugami M; Ito N
    Gan; 1972 Dec; 63(6):805. PubMed ID: 4346086
    [No Abstract]   [Full Text] [Related]  

  • 55. The cellular analysis of liver carcinogenesis. V. Ultrastructural alterations within hepatocellular carcinoma induced by ethionine.
    Merkow LP; Epstein SM; Slifkin M; Farber E; Pardo M
    Lab Invest; 1972 Mar; 26(3):300-5. PubMed ID: 4335732
    [No Abstract]   [Full Text] [Related]  

  • 56. Early elevation of alpha 1-fetoprotein in N-2-fluorenylacetamide hepatocarcinogenesis.
    Becker FF; Sell S
    Cancer Res; 1974 Oct; 34(10):2489-94. PubMed ID: 4412886
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of the model for end-stage liver disease and serum alpha-fetoprotein as prognostic predictors for hepatocellular carcinoma.
    Huo TI; Lee SD
    Liver Int; 2006 Dec; 26(10):1300-1. PubMed ID: 17105599
    [No Abstract]   [Full Text] [Related]  

  • 58. An apparent danazol-induced primary hepatocellular carcinoma: case report.
    Buamah PK
    J Surg Oncol; 1985 Feb; 28(2):114-6. PubMed ID: 2578590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Alpha fetoprotein in non-neoplastic liver diseases].
    Piantino P; Pecchio F; Gallo V; Giudice L; Bonardi O
    Minerva Med; 1981 May; 72(18):1125-9. PubMed ID: 6164959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proceedings: Serum alphafetoprotein levels in liver disease: relation to hepatocellular regeneration and development of hepatoma.
    Eleftheriou N; Thomas H; Heathcote J; Sherlock S
    Gut; 1975 Oct; 16(10):835. PubMed ID: 54283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.